Christopher Allen Baer serves as Executive at BioSig Technologies, Inc., where they oversee executive responsibilities. Since joining the company, Christopher Allen Baer has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jul 26, 2024 involved receiving (via award) 30,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jul 26, 2024 | BSGM | $0 | Award | 30,000 | $N/A | Discretionary |
Christopher Allen Baer currently holds 80,000 shares of BioSig Technologies, Inc. (BSGM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher Allen Baer has been a net neutral trader of BSGM stock. They have purchased $0 and sold $0 worth of shares.
Christopher Allen Baer's most recent insider trade was on Jul 26, 2024, when they sold 30,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted